About Us

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company has two product candidates in development.

Sollpura

Novel, biotechnology-derived pancreatic enzyme replacement therapy for the potential treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions.

Learn more about Sollpura

Blisibimod

BAFF inhibitor for the potential treatment of IgA nephropathy.

Learn more about Blisibimod